Identification of markers that distinguish adipose tissue and glucose and insulin metabolism using a multi-modal machine learning approach
Source check: Source checked. Not independent scientific confirmation.
Finding: Multimodal XGBoost ranked serum metabolites against measured glucose, insulin, adipose and ectopic-fat phenotypes in 53 men; the study reports specific associations, with small-cohort limits. Clinical, biochemical, MRI and metabolomic measures are the reference endpoints; result is an association/feature-importance analysis without external cohort validation.
Technology: multimodal extreme-gradient-boosting models rank predictors for glucose/insulin measures, adipose morphology and fat distribution.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- multimodal extreme-gradient-boosting models rank predictors for glucose/insulin measures, adipose morphology and fat distribution.
- Test and result
- Results associate named metabolites with fasting glucose/insulin, OGTT and adipocyte/ectopic-fat outcomes; 53 non-obese male participants.
- Limitation / still unknown
- Clinical, biochemical, MRI and metabolomic measures are the reference endpoints; result is an association/feature-importance analysis without external cohort validation. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41598-021-95688-y.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.